These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29886423)

  • 1. Upward Shift and Steepening of the Blood Pressure Response to Exercise in Hypertensive Subjects at High Altitude.
    Caravita S; Faini A; Baratto C; Bilo G; Macarlupu JL; Lang M; Revera M; Lombardi C; Villafuerte FC; Agostoni P; Parati G
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29886423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
    Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ
    Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambulatory blood pressure in untreated and treated hypertensive patients at high altitude: the High Altitude Cardiovascular Research-Andes study.
    Bilo G; Villafuerte FC; Faini A; Anza-Ramírez C; Revera M; Giuliano A; Caravita S; Gregorini F; Lombardi C; Salvioni E; Macarlupu JL; Ossoli D; Landaveri L; Lang M; Agostoni P; Sosa JM; Mancia G; Parati G
    Hypertension; 2015 Jun; 65(6):1266-72. PubMed ID: 25895588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study.
    Ihm SH; Jeon HK; Cha TJ; Hong TJ; Kim SH; Lee NH; Yoon JH; Yoon N; Hwang KK; Jo SH; Youn HJ
    Drug Des Devel Ther; 2016; 10():3817-3826. PubMed ID: 27920497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood Pressure Lowering With Nilvadipine in Patients With Mild-to-Moderate Alzheimer Disease Does Not Increase the Prevalence of Orthostatic Hypotension.
    de Heus RAA; Donders R; Santoso AMM; Olde Rikkert MGM; Lawlor BA; Claassen JAHR;
    J Am Heart Assoc; 2019 May; 8(10):e011938. PubMed ID: 31088188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study.
    Derosa G; Cicero AF; Bertone G; Piccinni MN; Fogari E; Ciccarelli L; Fogari R
    Clin Ther; 2004 Aug; 26(8):1228-36. PubMed ID: 15476904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Antihypertensive Drug Class Affect Day-to-Day Variability of Self-Measured Home Blood Pressure? The HOMED-BP Study.
    Asayama K; Ohkubo T; Hanazawa T; Watabe D; Hosaka M; Satoh M; Yasui D; Staessen JA; Imai Y;
    J Am Heart Assoc; 2016 Mar; 5(3):e002995. PubMed ID: 27009620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertension.
    Billecke SS; Marcovitz PA
    Vasc Health Risk Manag; 2013; 9():95-104. PubMed ID: 23662062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide.
    Segura J; Ruilope LM
    Vasc Health Risk Manag; 2013; 9():521-8. PubMed ID: 24082785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.
    Weir MR; Elkins M; Liss C; Vrecenak AJ; Barr E; Edelman JM
    Clin Ther; 1996; 18(3):411-28. PubMed ID: 8829017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
    Bobrie G;
    Clin Ther; 2012 Aug; 34(8):1720-34.e3. PubMed ID: 22853847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study.
    Kang SM; Youn JC; Chae SC; Park CG; Yang JY; Kim MH; Hong TJ; Kim CH; Kim JJ; Shin DG; Jeong JW; Yoon JH; Park SH; Kwon J; Cho SY
    Clin Ther; 2011 Dec; 33(12):1953-63. PubMed ID: 22136978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
    Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
    Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nifedipine and telmisartan for the treatment of hypertension: the TALENT study.
    Derosa G; Maffioli P
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1499-503. PubMed ID: 22103868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting lacidipine versus short-acting nifedipine in the treatment of asymptomatic acute blood pressure increase.
    Sánchez M; Sobrino J; Ribera L; Adrián MJ; Torres M; Coca A
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):479-84. PubMed ID: 10069685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic.
    Volpe M; Tocci G
    Vasc Health Risk Manag; 2012; 8():371-80. PubMed ID: 22745561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
    McGill JB; Reilly PA
    Clin Ther; 2001 Jun; 23(6):833-50. PubMed ID: 11440284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of orally administered telmisartan for the treatment of systemic hypertension in cats: Results of a double-blind, placebo-controlled, randomized clinical trial.
    Coleman AE; Brown SA; Traas AM; Bryson L; Zimmering T; Zimmerman A
    J Vet Intern Med; 2019 Mar; 33(2):478-488. PubMed ID: 30851066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy and safety of nifedipine coat-core versus amlodipine in the treatment of patients with mild-to-moderate essential hypertension. Hypertension Study Group.
    Zidek W; Spiecker C; Knaup G; Steindl L; Breuer HW
    Clin Ther; 1995; 17(4):686-700. PubMed ID: 8565032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.